June 5, 2024 11:45 AM EDT
News Briefing

Ar­riVent inks ADC deal with Al­pham­ab; An­nex­on's $125M of­fer­ing

ENDPOINTS

Plus, news about Equi­l­li­um and Struc­ture Ther­a­peu­tics:

Ar­riVent, Al­pham­ab team up on mul­ti-ADC col­lab: The com­pa­nies will work to­geth­er to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times